Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials

doi:10.3748/wjg.v32.i14.117396

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 14

This Article

(44)

(45)

(0)

(1346)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Apr 14, 2026; 32(14): 117396
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.117396

Full Size Figure Download Figure

Figure 1 The major innate immune cells in the metabolic dysfunction-associated steatotic liver disease liver. Some typical markers for mouse and human innate immune cells are listed. CD: Cluster of differentiation; MHC-II: Major histocompatibility complex II; HLA: Human leukocyte antigen; DC: Dendritic cell; ILC: Innate lymphoid cell; TCR: T cell receptor; MAIT: Mucosal-associated invariant T; NK: Natural killer cell; NKT: Natural killer T cell; MASLD: Metabolic dysfunction-associated steatotic liver disease.

Citation: Yang M, Olaoba OT, Chinwo SC, LeVasseur H, Zhou B, Kimchi ET, Staveley-O’Carroll KF, Li G. Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials. World J Gastroenterol 2026; 32(14): 117396
URL: https://www.wjgnet.com/1007-9327/full/v32/i14/117396.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i14.117396

Yang M, Olaoba OT, Chinwo SC, LeVasseur H, Zhou B, Kimchi ET, Staveley-O’Carroll KF, Li G. Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials. World J Gastroenterol 2026; 32(14): 117396 [DOI: 10.3748/wjg.v32.i14.117396]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.